Assignee
GOOD T CELLS INC
KR·12 granted patents·17 pending applications·8 citations·filing 2016–2025
Top patents by PatentIndex Score
29 records- 0192US11999785B2Binding molecule specific for Lrig-1 protein and use thereofGOOD T CELLS INC·Filed 2022·Granted Jun 4, 2024·1 cites·17 claims
- 0287US11091538B2Use of regulatory T cell-specific surface protein LRIG-1GOOD T CELLS INC·Filed 2018·Granted Aug 17, 2021·2 cites·4 claims
- 0385US11365249B2Binding molecule specific for Lrig-1 protein and use thereofGOOD T CELLS INC·Filed 2018·Granted Jun 21, 2022·2 cites·15 claims
- 0485US11279756B2Binding molecule specific for LRIG-1 protein and use thereofGOOD T CELLS INC·Filed 2018·Granted Mar 22, 2022·2 cites·12 claims
- 0580US2024156927A1Method for activating t cells for cancer treatmentGOOD T CELLS INC·Filed 2024·Application pending·0 cites
- 0678US11820801B2Fusion protein, and pharmaceutical composition for preventing or treating cancer, containing sameGOOD T CELLS INC·Filed 2019·Granted Nov 21, 2023·1 cites·17 claims
- 0776US11932686B2Use of regulatory T cell-specific surface protein LRIG-1GOOD T CELLS INC·Filed 2021·Granted Mar 19, 2024·0 cites·5 claims
- 0876US2022135662A1Novel use of regulatory t cell-specific surface protein lrig-1GOOD T CELLS INC·Filed 2022·Application pending·0 cites
- 0972US11969463B2Method for activating T cells for cancer treatmentGOOD T CELLS INC·Filed 2018·Granted Apr 30, 2024·0 cites·7 claims
- 1072US11918634B2Method for activating T cells for cancer treatmentGOOD T CELLS INC·Filed 2018·Granted Mar 5, 2024·0 cites·6 claims
- 1168US2024141036A1Epitope of Regulatory T Cell Surface Antigen, and Antibody Specifically Binding TheretoGOOD T CELLS INC·Filed 2024·Application pending·0 cites
- 1264US2020048335A1Novel use of regulatory t cell-specific surface protein lrig-1GOOD T CELLS INC·Filed 2019·Application pending·0 cites
- 1363US11345729B2Recombinant fusion protein of BAF57 and uses thereofGOOD T CELLS INC·Filed 2019·Granted May 31, 2022·0 cites·12 claims
- 1460US11414467B2Fusion protein comprising transcription modulation domain of p65 and protein transduction domain, and uses thereofGOOD T CELLS INC·Filed 2019·Granted Aug 16, 2022·0 cites·5 claims
- 1559US2025145708A1Epitope of Regulatory T Cell Surface Antigen and Antibody Specifically Binding TheretoGOOD T CELLS INC·Filed 2025·Application pending·0 cites
- 1658US2021363244A1Epitope of Regulatory T Cell surface Antigen and Antibody Specifically Biding TheretoGOOD T CELLS INC·Filed 2019·Application pending·0 cites
- 1758US2024301050A1Novel binding molecule and use thereofGOOD T CELLS INC·Filed 2022·Application pending·0 cites
- 1857US2023270787A1Cell surface antigen of activated immune cell and various uses thereofGOOD T CELLS INC·Filed 2021·Application pending·0 cites
- 1955US2019315820A1A Composition Containing SMAD Protein for Treatment of Autoimmune Diseases, a Fusion Protein Comprising SMAD Protein, an Expression Vector and a Method for Preparing the SameGOOD T CELLS INC·Filed 2019·Application pending·0 cites
- 2055US2019338001A1Composition Containing SMAD Protein for Treatment of Autoimmune Diseases, a Fusion Protein Comprising SMAD Protein, an Expression Vector and a Method for Preparing the SameGOOD T CELLS INC·Filed 2019·Application pending·0 cites
- 2154US2022275081A1Binding molecule specific for lrig-1 protein and use thereofGOOD T CELLS INC·Filed 2019·Application pending·0 cites
- 2254US2022275080A1Binding molecule specific to lrig-1 protein, and use thereofGOOD T CELLS INC·Filed 2019·Application pending·0 cites
- 2353US2025243272A1Epitope of regulatory t cell surface antigen, and antibody specifically binding theretoGOOD T CELLS INC·Filed 2020·Application pending·0 cites
- 2453US2022249684A1Composition for preventing, ameliorating or treating immune checkpoint inhibitor-resistant cancerGOOD T CELLS INC·Filed 2020·Application pending·0 cites
- 2552US11890364B2Composition for prevention or treatment of hair lossGOOD T CELLS INC·Filed 2018·Granted Feb 6, 2024·0 cites·11 claims
- 2652US10494411B2Fusion protein comprising transcription modulation domain of p65 and protein transduction domain, and uses thereofGOOD T CELLS INC·Filed 2016·Granted Dec 3, 2019·0 cites·2 claims
- 2752US2022213186A1Composition for preventing or treating brain and nervous system diseaseGOOD T CELLS INC·Filed 2020·Application pending·0 cites
- 2851US2023210896A9Method for t cell activation for cancer treatmentGOOD T CELLS INC·Filed 2020·Application pending·0 cites
- 2947US2021347849A1Composition for Preventing or Treating Immune-Related DiseasesGOOD T CELLS INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GOOD T CELLS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →